CRISPR And Axovant: What The Market Thinks – Seeking Alpha
|
CRISPR And Axovant: What The Market Thinks
Seeking Alpha Let's go to the NASDAQ for some insight on a couple of recent biopharma stories. First off is Axovant (NASDAQ:AXON), a company that's interesting in a number of distressing ways. I last wrote about them here, after their Alzheimer's candidate came up … |
